Rapid Micro Biosystems (RPID) Liabilities and Shareholders Equity (2020 - 2026)

Rapid Micro Biosystems has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $62.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 27.0% year-over-year to $62.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $297.2 million (down 26.89% YoY) and the FY2025 annual result came in at $74.9 million, down 23.75% from the prior year.
• Liabilities and Shareholders Equity eased to $62.4 million in Q1 2026 per RPID's latest filing, from $74.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $230.1 million in Q1 2022 and troughed at $62.4 million in Q1 2026.
• A 5-year average of $135.2 million and a median of $127.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity jumped 67.24% in 2022, then slumped 35.44% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $190.6 million in 2022, then slipped by 24.76% to $143.5 million in 2023, then plunged by 31.57% to $98.2 million in 2024, then dropped by 23.75% to $74.9 million in 2025, then declined by 16.68% to $62.4 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $62.4 million, $74.9 million, and $84.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.